Home
Celltrion

Celltrion Market Share Analysis for November 2025

Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea.

Health > Health - Other

Domaincelltrionph.com

Year Founded2002

Employees1001 - 5000

Annual Revenue> $1B

Celltrion

Celltrion (including company regionals)

celltrionph.com

See more website traffic and engagement information

Celltrion Revenue up to November 2025 is > 1B

revenue generated by Celltrion top domains

Celltrion top domains revenue over 3 years

Revenue for Celltrion top domains

celltrionph.com> 1B

See more with Sales Intelligence

Celltrion Stock price in November 2025

Celltrion stock is traded under the ticker #068270. Below you can review Celltrion stock performance in the past 12 months up to November 2025

Total visits to Celltrion's top domains

Understand Celltrion market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

celltrionph.com37.3K

See more with Sales Intelligence

Avg. visit duration in Celltrion's top domains

Analyze Celltrion engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

celltrionph.com00:14:21

See more with Sales Intelligence

Avg. pageviews on Celltrion's top domains

See how Celltrion keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

celltrionph.com79.96

See more with Sales Intelligence

Celltrion top competitors by domain

Top similar sites in November 2025, ranked by their affinity

hanmi.co.krCompany NameHanmi PharmEmployees1001 - 5000HQKorea, Republic of, SeoulAnnual revenue$5M - $10MTotal visits74.4KHealth > Health - Other

Top technologies used by Celltrion

These are the website technologies, by industry, used by Celltrion top domains

Advertising (1)

PubMatic

Audio Video Media (1)

Vimeo

Conversion & Analytics (1)

Google Analytics

Email Services (1)

Microsoft Exchange Online

More Technologies

4

See all

News & Signals from Celltrion

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCelltrion Pharm, Inc. expands facilities to Cheongju, South Korea.To address rising demand for PFS production, Celltrion Pharm is expanding its production line at the Cheongju plant.

NewsCelltrion Pharm, Inc. recognized as Grand Prize in the pharmaceutical sector of the public and medical category.Celltrion announced on the 19th that it has won the Grand Prize in the pharmaceutical sector of the public and medical category at the 'Web Award Korea 2024.'

NewsCelltrion Pharm, Inc. launched autoimmune disease treatment Stekima and the ophthalmic disease treatment Idenelt on Nov 15th '25.In particular, Celltrion is preparing to launch the autoimmune disease treatment "Stekima" (Stelara biosimilar) and the ophthalmic disease treatment "Idenelt" (Eylea biosimilar) next year, and the expansion of treatment areas and diversification of the product portfolio are expected to generate synergies.